200 related articles for article (PubMed ID: 1457766)
1. Does antihypertensive treatment prevent progression of microalbuminuria to overt proteinuria in insulin-dependent diabetic patients?
Passa P
J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S91-6. PubMed ID: 1457766
[TBL] [Abstract][Full Text] [Related]
2. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.
Parving HH; Rossing P
Curr Opin Nephrol Hypertens; 1994 May; 3(3):292-300. PubMed ID: 7922255
[TBL] [Abstract][Full Text] [Related]
3. Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
[TBL] [Abstract][Full Text] [Related]
4. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
Parving HH
J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
6. Is antihypertensive treatment the same for NIDDM and IDDM patients?
Parving HH
Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
[TBL] [Abstract][Full Text] [Related]
7. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus.
Mogensen CE; Petersen MM; Hansen KW; Christensen CK
J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502
[TBL] [Abstract][Full Text] [Related]
8. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
Zanella MT; Ribeiro AB
Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
[TBL] [Abstract][Full Text] [Related]
9. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
[TBL] [Abstract][Full Text] [Related]
10. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
11. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
Jerums G; MacIsaac RJ
Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
[TBL] [Abstract][Full Text] [Related]
12. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Ruilope LM; Segura J
Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
[TBL] [Abstract][Full Text] [Related]
13. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2007 Jul; (1):CD002183. PubMed ID: 17636698
[TBL] [Abstract][Full Text] [Related]
15. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
Chiarelli F; Verrotti A; Mohn A; Morgese G
Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
[TBL] [Abstract][Full Text] [Related]
16. Preventing end-stage renal disease.
Mogensen CE
Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2001; (1):CD002183. PubMed ID: 11279757
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
Donnelly R; Molyneaux LM; Willey KA; Yue DK
Am J Cardiol; 1996 Feb; 77(6):26B-30B. PubMed ID: 8848991
[TBL] [Abstract][Full Text] [Related]
19. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2000; (2):CD002183. PubMed ID: 10796871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
